A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology

Veterinary and Comparative Oncology

Volumn 7, Issue 2, 2009, Pages 81-91

  Tuohy, J L ^a   Milgram, J ^b   Worley, D R ^a   Dernell, W S ^a,c  

^a Department of Ecosystem Science and Sustainability   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Comparative oncology; Lymphoscintigraphy; Metastasis; Sentinel lymph node; Surgical oncology

Indexed keywords

ANIMAL; ANIMAL DISEASE; CANCER INVASION; CANCER STAGING; LYMPH NODE; LYMPH NODE METASTASIS; MORTALITY; NEOPLASM; ONCOLOGY; PATHOLOGY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; VETERINARY MEDICINE;

ANIMALS; LYMPH NODES; LYMPHATIC METASTASIS; MEDICAL ONCOLOGY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; VETERINARY MEDICINE;

EID: 65749100550     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2009.00183.x     Document Type: Review

References (82)

1. Goyal A and Mansel RE. Recent advances in sentinel lymph node biopsy for breast cancer. Current Opinion in Oncology 2008; 20: 621-626.
2. Cochran AJ, Ohsie SJ and Binder SW. Pathobiology of the sentinel node. Current Opinion in Oncology 2008; 20: 190-195.
3. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-466.
4. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ and Cochran AJ. Technical details of intraoperative lymphatic mapping for early stage melanoma. Archives of Surgery 1992; 127: 392-399.
5. Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G and Winer EP. Complications of axillary lymph node dissection for carcinoma of the breast: A report based on a patient survey. Cancer 1998; 83: 1362-1368.
6. Goyal A and Mansel RE. Current status of sentinel lymph node biopsy in solid malignancies. World Journal of Surgical Oncology 2004; 2: 9.
7. Yudd AP, Kempf JS, Goydos JS, Stahl TJ and Feinstein RS. Use of sentinel node lymphoscintigraphy in malignant melanoma. Radiographics 1999; 19: 343-353, Discussion 54-6.
8. Bendavid Y, Latulippe JF, Younan RJ, Leclerc YE, Dube S, Heyen F, Morin M, Girard R, Bastien E, Ferreira J, Cerino M and Dube P. Phase I study on sentinel lymph node mapping in colon cancer: A preliminary report. Journal of Surgical Oncology 2002; 79: 81-84, Discussion 5.
9. Esser S, Reilly WT, Riley LB, Eyvazzadeh C and Arcona S. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Diseases of the Colon & Rectum 2001; 44: 850-854, Discussion 4-6.
10. Wiseman SM, Loree TR, Hicks WL Jr, and Rigual NR. Sentinel lymph node biopsy in SCC of the head and neck: A major advance in staging the N0 neck. Ear Nose & Throat Journal 2002; 81: 156-160, 63.
11. Altinyollar H, Berberoglu U and Celen O. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. European Journal of Surgical Oncology 2002; 28: 72-74.
12. Holub Z, Jabor A and Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: A pilot study. European Journal of Gynaecological Oncology 2002; 23: 53-57.
13. Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK and Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecologic Oncology 2001; 83: 276-281.
14. Sliutz G, Reinthaller A, Lantzsch T, Mende T, Sinzinger H, Kainz C and Koelbl H. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecologic Oncology 2002; 84: 449-452.
15. Gallowitsch HJ, Mikosch P, Kresnik E, Starlinger M and Lind P. Lymphoscintigraphy and gamma probe-guided surgery in papillary thyroid carcinoma: The sentinel lymph node concept in thyroid carcinoma. Clinical Nuclear Medicine 1999; 24: 744-746.
16. Fukui Y, Yamakawa T, Taniki T, Numoto S, Miki H and Monden Y. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001; 92: 2868-2874.
17. Mehrany K, Otley CC, Weenig RH, Phillips PK, Roenigk RK and Nguyen TH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatologic Surgery 2002; 28: 113-117, Discussion 7.
18. Coit DG. Merkel cell carcinoma. Annals of Surgical Oncology 2001; 8 Suppl. 9 99S-102S.
19. Allen PJ, Busam K, Hill AD, Stojadinovic A and Coit DG. Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer 2001; 92: 1650-1655.
20. Yasuda S, Shimada H, Ogoshi K, Tanaka H, Kise Y, Kenmochi T, Soeda J, Nakamura K, Kato Y, Kijima H, Suzuki Y, Fujii H, Tajima T and Makuuchi H. Preliminary study for sentinel lymph node identification with Tc-99m tin colloid in patients with esophageal or gastric cancer. Tokai Journal of Experimental & Clinical Medicine 2001; 26: 15-18.
21. Aikou T, Higashi H, Natsugoe S, Hokita S, Baba M and Tako S. Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer? Annals of Surgical Oncology 2001; 8 Suppl. 9 90S-93S.
22. Liptay MJ, Grondin SC, Fry WA, Pozdol C, Carson D, Knop C, Masters GA, Perlman RM and Watkin W. Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases. Journal of Clinical Oncology 2002; 20: 1984-1988.
23. Rovera F, Frattini F, Marelli M, Corben AD, Dionigi G, Boni L and Dionigi R. Axillary sentinel lymph node biopsy: An overview. International Journal of Surgery 2008;. Doi:10.1016/j.ijsu.2008.12.008.
24. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, Weaver DL, Miller BJ, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Mammolito DM, McCready DR, Mamounas EP, Costantino JP and Wolmark N. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 randomised phase III trial. Lancet Oncology 2007; 8: 881-888.
25. Luini A, Gatti G, Ballardini B, Zurrida S, Galimberti V, Veronesi P, Vento AR, Montis S, Viale G, Pagnnelli G and Veronesi U. Development of axillary surgery in breast cancer. Annals of Oncology 2005; 16: 259-262.
26. Herring ES, Smith MM and Robertson JL. Lymph node staging of oral and maxillofacial neoplasms in 31 dogs and cats. Journal of Veterinary Dentistry 2002; 19: 122-126.
27. Williams LE and Packer RA. Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987-2001). Journal of the American Veterinary Medical Association 2003; 222: 1234-1236.
28. Langenbach A, McManus PM, Hendrick MJ, Shofer FS and Sorenmo KU. Sensitivity and specificity of methods of assessing the regional lymph nodes for evidence of metastasis in dogs and cats with solid tumors. Journal of the American Veterinary Medical Association 2001; 218: 1424-1428.
29. Della Santa D, Gaschen L, Doherr MG, Citi S, Marchetti V and Lang J. Spectral waveform analysis of intranodal arterial blood flow in abnormally large superficial lymph nodes in dogs. American Journal of Veterinary Research 2008; 69: 478-485.
30. Faries MB and Morton DL. Surgery and sentinel lymph node biopsy. Seminars in Oncology 2007; 34: 498-508.
31. Lurie DM, Seguin B, Schneider PD, Verstraete FJ and Wisner ER. Contrast-assisted ultrasound for sentinel lymph node detection in spontaneously arising canine head and neck tumors. Investigative Radiology 2006; 41: 415-421.
32. Yamagami T, Kobayashi T, Takahashi K and Sugiyama M. Prognosis for canine malignant mammary tumors based on TNM and histologic classification. Journal of Veterinary Medical Science 1996; 58: 1079-1083.
33. Chang SC, Chang CC, Chang TJ and Wong ML. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002). Journal of the American Veterinary Medical Association 2005; 227: 1625-1629.
34. Bergman PJ. Canine oral melanoma. Clinical Techniques in Small Animal Practice 2007; 22: 55-60.
35. Kirpensteijn J, Kik M, Rutteman GR and Teske E. Prognostic significance of a new histologic grading system for canine osteosarcoma. Veterinary Pathology 2002; 39: 240-246.
36. Hillers KR, Dernell WS, Lafferty MH, Withrow SJ and Lana SE. Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). Journal of the American Veterinary Medical Association 2005; 226: 1364-1367.
37. McNiel EA, Ogilvie GK, Powers BE, Hutchison JM, Salman MD and Withrow SJ. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992). Journal of the American Veterinary Medical Association 1997; 211: 1422-1427.
38. Ogilvie GK, Weigel RM, Haschek WM, Withrow SJ, Richardson RC, Harvey HJ, Henderson RA, Fowler JD, Norris AM, Tomlinson J, McCaw D, Klausner JS, Reschke RW and McKiernan BC. Prognostic factors for tumor remission and survival in dogs after surgery for primary lung tumor: 76 cases (1975-1985). Journal of the American Veterinary Medical Association 1989; 195: 109-112.
39. Vail DM, Powers BE, Getzy DM, Morrison WB, McEntee MC, O'Keefe DA, Norris AM and Withrow SJ. Evaluation of prognostic factors for dogs with synovial sarcoma: 36 cases (1986-1991). Journal of the American Veterinary Medical Association 1994; 205: 1300-1307.
40. Murphy S, Sparkes AH, Blunden AS, Brearley MJ and Smith KC. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. Veterinary Record 2006; 158: 287-291.
41. Uren RF, Thompson JF, Howman-Giles R and Chung DK. The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma. Surgical Oncology Clinics of North America 2006; 15: 285-300.
42. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG and Frangioni JV. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nature Biotechnology 2004; 22: 93-97.
43. Goyal A, Newcombe RG, Mansel RE, Chetty U, Ell P, Fallowfield L, Kissin M and Sibbering M. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. European Journal of Cancer 2005; 41: 238-243.
44. Glass EC. Sentinel node identification using radionuclides in melanoma and breast cancer. Cancer Treatment and Research 2007; 135: 85-100.
45. Todoroff RJ and Brodey RS. Oral and pharyngeal neoplasia in the dog: A retrospective survey of 361 cases. Journal of the American Veterinary Medical Association 1979; 175: 567-571.
46. Ramos-Vara JA, Beissenherz ME, Miller MA, Johnson GC, Pace LW, Fard A and Kottler SJ. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Veterinary Pathology 2000; 37: 597-608.
47. Patsikas MN, Karayannopoulou M, Kaldrymidoy E, Papazoglou LG, Papadopoulou PL, Tzegas SI, Tziris NE, Kaitzis DG, Dimitriadis AS and Dessiris AK. The lymph drainage of the neoplastic mammary glands in the bitch: A lymphographic study. Anatomia Histologia Embryologia-Journal of Veterinary Medicine Series C 2006; 35: 228-234.
48. Patsikas MN and Dessiris A. The lymph drainage of the mammary glands in the Bitch: A lymphographic study. Part II: The 3rd mammary gland. Anatomia Histologia Embryologia-Journal of Veterinary Medicine Series C 1996; 25: 139-143.
49. Patsikas MN and Dessiris A. The lymph drainage of the mammary glands in the bitch: A lymphographic study. Part I: The 1st, 2nd, 4th and 5th mammary glands. Anatomia Histologia Embryologia-Journal of Veterinary Medicine Series C 1996; 25: 131-138.
50. Yamagami T, Kobayashi T, Takahashi K and Sugiyama M. Influence of ovariectomy at the time of mastectomy on the prognosis for canine malignant mammary tumours. Journal of Small Animal Practice 1996; 37: 462-464.
51. Kurzman ID and Gilbertson SR. Prognostic factors in canine mammary tumors. Seminars in Veterinary Medicine and Surgery-Small Animal 1986; 1: 25-32.
52. Gilbertson SR, Kurzman ID, Zachrau RE, Hurvitz AI and Black MM. Canine mammary epithelial neoplasms: Biologic implications of morphologic characteristics assessed in 232 dogs. Veterinary Pathology 1983; 20: 127-142.
53. de Freitas R Jr, Costa MV, Schneider SV, Nicolau MA and Marussi E. Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. European Journal of Surgical Oncology 1991; 17: 240-244.
54. Gilson SD. Clinical management of the regional lymph node. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 149-167.
55. Gadd MA, Cosimi AB, Yu J, Duncan LM, Yu L, Flotte TJ, Souba WW, Ott MJ, Wong LS, Sober AJ, Mihm MO, Haluska FG and Tanabe KK. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Archives of Surgery 1999; 134: 381-387.
56. Julian TB, Blumencranz P, Deck K, Whitworth P, Berry DA, Berry SM, Rosenberg A, Chagpar AB, Reintgen D, Beitsch P, Simmons R, Saha S, Mamounas EP and Giuliano A. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. Journal of Clinical Oncology 2008; 26: 3338-3345.
57. van Deurzen CH, Seldenrijk CA, Koelemij R, van Hillegersberg R, Hobbelink MG and van Diest PJ. The microanatomic location of metastatic breast cancer in sentinel lymph nodes predicts nonsentinel lymph node involvement. Annals of Surgical Oncology 2008; 15: 1309-1315.
58. Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, Wanek LA, Glass E, Foshag LJ, Hsueh EC, Bilchik AJ, Elashoff D and Elashoff R. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Annals of Surgery 2003; 238: 538-549, Discussion 49-50.
59. Amersi F and Morton DL. The role of sentinel lymph node biopsy in the management of melanoma. Advances in Surgery 2007; 41: 241-256.
60. Woo SU, Bae JW, Yang JH, Kim JH, Nam SJ and Shin YK. Overexpression of interleukin-10 in sentinel lymph node with breast cancer. Annals of Surgical Oncology 2007; 14: 3268-3273.
61. Leong SP, Peng M, Zhou YM, Vaquerano JE and Chang JW. Cytokine profiles of sentinel lymph nodes draining the primary melanoma. Annals of Surgical Oncology 2002; 9: 82-87.
62. Velanovich V and Szymanski W. Quality of life of breast cancer patients with lymphedema. American Journal of Surgery 1999; 177: 184-187, Discussion 8.
63. Balogh L, Thuroczy J, Andocs G, Mathe D, Chaudhari P, Perge E, Biksi I, Polyak A, Kiraly R and Janoki GA. Sentinel lymph node detection in canine oncological patients. Nuclear Medicine Review 2002; 5: 139-144.
64. Wells S, Bennett A, Walsh P, Owens S and Peauroi J. Clinical usefulness of intradermal fluorescein and patent blue violet dyes for sentinel lymph node identification in dogs. Veterinary and Comparative Oncology 2006; 4: 114-122.
65. Nwogu CE, Kanter PM and Anderson TM. Pulmonary lymphatic mapping in dogs: Use of technetium sulfur colloid and isosulfan blue for pulmonary sentinel lymph node mapping in dogs. Cancer Investigation 2002; 20: 944-947.
66. Kersey TW, Van Eyk J, Lannin DR, Chua AN and Tafra L. Comparison of intradermal and subcutaneous injections in lymphatic mapping. Journal of Surgical Research 2001; 96: 255-259.
67. Wong JH, Cagle LA and Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Annals of Surgery 1991; 214: 637-641.
68. Nyman HT and O'Brien RT. The sonographic evaluation of lymph nodes. Clinical Techniques in Small Animal Practice 2007; 22: 128-137.
69. Parungo CP, Ohnishi S, Kim SW, Kim S, Laurence RG, Soltesz EG, Chen FY, Colson YL, Cohn LH, Bawendi MG and Frangioni JV. Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. Journal of Thoracic and Cardiovascular Surgery 2005; 129: 844-850.
70. Soltesz EG, Kim S, Laurence RG, DeGrand AM, Parungo CP, Dor DM, Cohn LH, Bawendi MG, Frangioni JV and Mihaljevic T. Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Annals of Thoracic Surgery 2005; 79: 269-277, Discussion -77.
71. Soltesz EG, Kim S, Kim SW, Laurence RG, De Grand AM, Parungo CP, Cohn LH, Bawendi MG and Frangioni JV. Sentinel lymph node mapping of the gastrointestinal tract by using invisible light. Annals of Surgical Oncology 2006; 13: 386-396.
72. Parungo CP, Colson YL, Kim SW, Kim S, Cohn LH, Bawendi MG and Frangioni JV. Sentinel lymph node mapping of the pleural space. Chest 2005; 127: 1799-1804.
73. Parungo CP, Soybel DI, Colson YL, Kim SW, Ohnishi S, DeGrand AM, et al. Lymphatic drainage of the peritoneal space: A pattern dependent on bowel lymphatics. Annals of Surgical Oncology 2007; 14: 286-298.
74. Frangioni JV, Kim SW, Ohnishi S, Kim S and Bawendi MG. Sentinel lymph node mapping with type-II quantum dots. Methods in Molecular Biology 2007; 374: 147-159.
75. Knapp DW, Adams LG, Degrand AM, Niles JD, Ramos-Vara JA, Weil AB, O'Donnell MA, Lucroy MD and Frangioni JV. Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. European Urology 2007; 52: 1700-1708.
76. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakovsis CP, Mozzillon N, Reintgen D, Wang HJ, Glass EC and Cochran AJ. Multicenter Selective Lymphadenectomy Trial Group. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Annals of Surgery 1999; 230: 453-463, Discussion 63-5.
77. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF and McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node. Journal of Nuclear Medicine 1993; 34: 1435-1440.
78. Thompson JF, Uren RF, Shaw HM, McCarthy WH, Quinn MJ, O'Brien CJ and Howman-Giles RB. Location of sentinel lymph nodes in patients with cutaneous mela-noma: New insights into lymphatic anatomy. Journal of the American College of Surgeons 1999; 189: 195-204.
79. Balch CM and Lange JR. Lymphatic mapping and sentinel node lymphadenectomy for cancer: An overview. Annals of Surgical Oncology 2001; 8 Suppl. 9 1S-4S.
80. Canavese G, Gipponi M, Catturich A, Di Somma C, Vecchio C, Rosato F, Percivale P, Moresco L, Nicolo G, Spina B, Villa G, Bianchi P and Badellino F. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery. Journal of Surgical Oncology 2000; 74: 61-68.
81. Saha S, Dan AG, Beutler T, Wiese D, Schochet E, Badin J, Branigan T, Ng P, Brassily N and David D. Sentinel lymph node mapping technique in colon cancer. Seminars in Oncology 2004; 31: 374-381.
82. Braat AE, Oosterhuis JW, Moll FC and de Vries JE. Successful sentinel node identification in colon carcinoma using Patent Blue V. European Journal of Surgical Oncology 2004; 30: 633-637.